Tectol

Tectol may be available in the countries listed below.

Ingredient matches for Tectol

Magnesium Citrate

Magnesium Citrate is reported as an ingredient of Tectol in the following countries:

• Japan

International Drug Name Search

Dapson

Dapson may be available in the countries listed below.

Ingredient matches for Dapson

Dapsone

Dapsone is reported as an ingredient of Dapson in the following countries:

• Norway

International Drug Name Search

Beconase AQ Spray

Pronunciation: be-kloe-METH-ah-sone
Generic Name: Beclomethasone
Brand Name: Beconase AQ

Beconase AQ Spray is used for:

Treating nasal allergy symptoms. It is also used to prevent recurrence of nasal growths (polyps) after surgical removal. It may also be used for other conditions as determined by your doctor.

Beconase AQ Spray is a corticosteroid. It works by shrinking swollen and inflamed nasal tissue and by blocking the action of certain cells and chemicals of the immune system.

Do NOT use Beconase AQ Spray if:

• you are allergic to any ingredient in Beconase AQ Spray

Contact your doctor or health care provider right away if any of these apply to you.

Before using Beconase AQ Spray:

Some medical conditions may interact with Beconase AQ Spray. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a bacterial, viral, fungal, or parasitic infection; chickenpox; tuberculosis; a positive tuberculosis (TB) skin test; measles; diarrhea; nasal ulcer, surgery, or trauma; or herpes infection in the eye; or if you have had a recent vaccine


• if you have a very runny nose

Some MEDICINES MAY INTERACT with Beconase AQ Spray. Because little, if any, of Beconase AQ Spray is absorbed into the blood, the risk of it interacting with another medicine is low.

Ask your health care provider if Beconase AQ Spray may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Beconase AQ Spray:

Use Beconase AQ Spray as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• An extra patient leaflet is available with Beconase AQ Spray. Talk to your pharmacist if you have questions about this information.


• Beconase AQ Spray is only for the nose.


• Shake well before each use.


• Before using Beconase AQ Spray for the first time, gently shake the container and prime the pump by spraying 6 times or until a fine spray appears.


• Clear your nose before using Beconase AQ Spray by blowing it gently.


• Tilt your head forward slightly. Carefully insert the applicator into the nostril, keeping the bottle upright. Breathe gently inward through the nostril while spraying. Breathe out through your mouth.


• Use Beconase AQ Spray on a regular schedule to get the most benefit from it.


• Always replace the cap and clip when finished.


• Beconase AQ Spray works best if used on a regular basis.


• To clean, gently remove the nasal applicator from the bottle. Wash the applicator and cap with cold water. Dry and replace.


• If the pump becomes blocked, unscrew the pump and soak in warm water for a few minutes. Rinse with cold water, dry, and replace. Reprime the pump.


• If your symptoms do not get better within 2 weeks or if they get worse, check with your doctor.


• Throw the bottle away after 180 sprays following the priming of the bottle. The correct amount of medication in each spray cannot be ensured after a certain number of uses. Do not transfer any remaining suspension to another bottle.


• Continue to use Beconase AQ Spray even if you feel well.


• If you miss a dose of Beconase AQ Spray, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Beconase AQ Spray.

Important safety information:

• If switching from an oral steroid medicine to an inhaled one, contact your doctor at once if withdrawal symptoms (eg, muscle and joint pain, exhaustion, depression) occur.


• Use caution if you switch from an oral steroid (eg, prednisone) to Beconase AQ Spray. It may take several months for your body to make enough natural steroids to handle events that cause physical stress. Such events may include injury, surgery, infection, loss of blood electrolytes, or a sudden asthma attack. These may be severe and sometimes fatal. Contact your doctor right away if any of these events occur. You may need to take an oral steroid (eg, prednisone) again. Carry a card at all times that says you may need an oral steroid (eg, prednisone) if any of these events occur.


• Avoid spraying in the eyes. If you get Beconase AQ Spray in your eyes, rinse immediately with cool water.


• Always have a spare inhaler available in case the unit malfunctions or is empty.


• If you have not had chickenpox, shingles, or measles, avoid contact with anyone who does.


• Corticosteroids may affect growth rate in CHILDREN and teenagers in some cases. They may need regular growth checks while they use Beconase AQ Spray.


• Beconase AQ Spray should not be used in CHILDREN younger than 6 years old; safety and effectiveness in these children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Beconase AQ Spray while you are pregnant. It is not known if Beconase AQ Spray is found in breast milk. If you are or will be breast-feeding while you use Beconase AQ Spray, check with your doctor. Discuss any possible risks to your baby.

Possible side effects of Beconase AQ Spray:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Bad taste; coughing; headache; hoarseness; nasal irritation or dryness; nausea; sore throat.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue; unusual hoarseness); acne-like rash; continuing nose discomfort; excessive sneezing; increased pressure in the eye; infection (fever, chills, sore throat); irregular menstrual period; loss of taste or smell; nosebleeds or soreness; pounding in the chest; unusual weight gain, especially in the face; vision changes; wheezing.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Beconase AQ side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include increased thirst or urination; muscle weakness; unusual weight gain, especially in the face.

Proper storage of Beconase AQ Spray:

Store at room temperature, between 59 and 86 degrees F (15 and 30 degrees C), in an upright position. Store away from heat, moisture, and light. Do not freeze. Keep Beconase AQ Spray out of the reach of children and away from pets.

General information:

• If you have any questions about Beconase AQ Spray, please talk with your doctor, pharmacist, or other health care provider.


• Beconase AQ Spray is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Beconase AQ Spray. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Beconase AQ resources

• Beconase AQ Side Effects (in more detail)
• Beconase AQ Use in Pregnancy & Breastfeeding
• Beconase AQ Support Group
• 0 Reviews for Beconase AQ - Add your own review/rating

Compare Beconase AQ with other medications

• Hay Fever
• Nasal Polyps
• Nasal Polyps, Prevention

Dicloratio

Dicloratio may be available in the countries listed below.

Ingredient matches for Dicloratio

Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Dicloratio in the following countries:

• Poland

International Drug Name Search

Blindafe

Blindafe may be available in the countries listed below.

Ingredient matches for Blindafe

Alendronic Acid

Alendronic Acid sodium trihydrate (a derivative of Alendronic Acid) is reported as an ingredient of Blindafe in the following countries:

• Mexico

International Drug Name Search

TFX

TFX may be available in the countries listed below.

Ingredient matches for TFX

Thymostimulin

Thymostimulin is reported as an ingredient of TFX in the following countries:

• Poland

International Drug Name Search

Diazoxide

In some countries, this medicine may only be approved for veterinary use.

In the US, Diazoxide (diazoxide systemic) is a member of the following drug classes: agents for hypertensive emergencies, glucose elevating agents and is used to treat Hypertensive Emergency and Hypoglycemia.

US matches:

• Diazoxide Suspension


• Diazoxide


• Diazoxide, Oral

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C02DA01,V03AH01

CAS registry number (Chemical Abstracts Service)

0000364-98-7

Chemical Formula

C8-H7-Cl-N2-O2-S

Molecular Weight

230

Therapeutic Category

Antihypertensive agent

Chemical Name

2H-1,2,4-Benzothiadiazine, 7-chloro-3-methyl-, 1,1-dioxide

Foreign Names

• Diazoxidum (Latin)
• Diazoxid (German)
• Diazoxide (French)
• Diazoxido (Spanish)

Generic Names

• Diazossido (OS: DCIT)
• Diazoxide (OS: USAN, DCF, BAN)
• NSC 64198 (IS)
• Sch 6783 (IS: Schering)
• SRG 95213 (IS)
• Diazoxid (PH: Ph. Eur. 6)
• Diazoxide (PH: BP 2010, Ph. Int. 4, USP 32, Ph. Eur. 6)
• Diazoxidum (PH: Ph. Int. 4, Ph. Eur. 6)

Brand Names

• Diazoxide Double-Crane Pharm
  Double-Crane, China



• Diazoxide
  Hospira, Australia; Hospira, New Zealand



• Eudemine
  Goldshield, United Kingdom; UCB Pharma, United Kingdom



• Eudemine (veterinary use)
  UCB, United Kingdom



• Hyperstat I.V.
  Schering, United States



• Hyperstat
  Schering, United States



• Proglicem
  Essex, Germany; Essex Chemie, Switzerland; Schering-Plough, Argentina; Schering-Plough, France; Schering-Plough, Italy; Schering-Plough, Netherlands



• Proglycem
  Gate, United States; Schering-Plough, Canada



• Tensuril
  Cristália, Brazil

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Kinestase

Kinestase may be available in the countries listed below.

Ingredient matches for Kinestase

Cisapride

Cisapride monohydrate (a derivative of Cisapride) is reported as an ingredient of Kinestase in the following countries:

• Mexico

International Drug Name Search

Depnil

Depnil may be available in the countries listed below.

Ingredient matches for Depnil

Moclobemide

Moclobemide is reported as an ingredient of Depnil in the following countries:

• South Africa

International Drug Name Search

Dorner

Dorner may be available in the countries listed below.

Ingredient matches for Dorner

Beraprost

Beraprost sodium (a derivative of Beraprost) is reported as an ingredient of Dorner in the following countries:

• China


• Indonesia


• Japan

International Drug Name Search

Kreval

Kreval may be available in the countries listed below.

Ingredient matches for Kreval

Butamirate

Butamirate citrate (a derivative of Butamirate) is reported as an ingredient of Kreval in the following countries:

• Turkey

International Drug Name Search

Actazolam

Actazolam may be available in the countries listed below.

Ingredient matches for Actazolam

Alprazolam

Alprazolam is reported as an ingredient of Actazolam in the following countries:

• Indonesia

International Drug Name Search